Alzheimer’s: Structural properties of complex model membranes after interaction with beta-amyloid peptides open the way to the identification of new drug targets

A new report describes the structural properties of complex model membranes after the interaction with beta-amyloid peptides, involved in Alzheimer’s disease, opening the way to the identification of new drug targets.